A new review article is drawing attention to the growing global impact of human papillomavirus (HPV) and the rapid progress in vaccines and therapeutic strategies aimed at reducing the burden of cervical and non-cervical cancers. The article highlights how evolving approaches are reshaping prevention, treatment, and long-term disease management.
HPV remains a leading cause of multiple cancers, including cervical, anal, oropharyngeal, and genital malignancies, affecting both women and men. Persistent infection with high-risk viral types plays a central role in cancer development by disrupting normal cellular processes and promoting genomic instability.
Recent advances in prophylactic vaccines have significantly strengthened prevention efforts. Current vaccines provide strong protection against the most dangerous HPV strains, helping to reduce infection rates and precancerous changes. New-generation vaccines are being developed to expand coverage and protect against a broader range of cancer-causing variants, increasing their global reach and effectiveness.
Beyond prevention, innovative therapeutic vaccines are emerging as powerful tools to target existing HPV-related cancers. These approaches focus on activating the body’s immune response, particularly T-cell activity, to identify and eliminate infected cells. Key viral components such as E6 and E7 proteins are central targets, enabling more precise and effective treatment strategies.
The article also highlights the promise of advanced technologies, including gene editing and immunotherapy. Techniques such as CRISPR-based approaches, DNA vaccines, and immune checkpoint inhibition are opening new pathways for treating HPV-driven cancers. These innovations aim to enhance immune recognition, remove infected cells, and improve clinical outcomes.
At the same time, progress in clinical management continues to refine traditional treatments such as surgery, chemotherapy, and radiotherapy. Improved methods are helping to reduce side effects while maintaining strong effectiveness, particularly in HPV-positive cancers, which often show better treatment responsiveness.
A growing emphasis on personalized medicine is also shaping the future of care, integrating prevention, early detection, and targeted therapies to address the complexity of HPV-related diseases.
Overall, this article underscores a rapidly advancing field where vaccination, immunotherapy, and precision treatment are converging. These developments mark a significant step forward in reducing the global burden of HPV-related cancers and improving outcomes for patients worldwide.
# # # # # #
Genes & Diseases publishes rigorously peer-reviewed and high quality original articles and authoritative reviews that focus on the molecular bases of human diseases. Emphasis is placed on hypothesis-driven, mechanistic studies relevant to pathogenesis and/or experimental therapeutics of human diseases. The journal has worldwide authorship, and a broad scope in basic and translational biomedical research of molecular biology, molecular genetics, and cell biology, including but not limited to cell proliferation and apoptosis, signal transduction, stem cell biology, developmental biology, gene regulation and epigenetics, cancer biology, immunity and infection, neuroscience, disease-specific animal models, gene and cell-based therapies, and regenerative medicine.
Scopus CiteScore: 8.4 |Impact Factor: 9.4
# # # # # #
More information: https://www.keaipublishing.com/en/journals/genes-and-diseases/
Editorial Board: https://www.keaipublishing.com/en/journals/genes-and-diseases/editorial-board/
All issues and articles in press are available online in ScienceDirect (https://www.sciencedirect.com/journal/genes-and-diseases).
Submissions to Genes & Diseases may be made using Editorial Manager (https://www.editorialmanager.com/gendis/default.aspx).
Print ISSN: 2352-4820
eISSN: 2352-3042
CN: 50-1221/R
Contact Us: editor@genesndiseases.cn
X (formerly twitter): @GenesNDiseases (https://x.com/GenesNDiseases)
# # # # # #
Reference
Md Rezaul Islam, Abdur Rauf, Most Nazmin Aktar, Md Naeem Hossain Fakir, Sadiya Islam Trisha, Asraful Islam Asif, Md Harun Or Rashid, Md Ibrahim Khalil Al-Imran, Gazi Kaifeara Thufa, Farhana Prodhan Emu, Hassan A. Hemeg, Hanan A. Ogaly, Rekha Thiruvengadam, Seung-Hyun Kim, Muthu Thiruvengadam, Recent advances in human papillomavirus vaccines and therapeutic strategies: Combating cervical and non-cervical cancers, Genes & Diseases, Volume 13, Issue 3, 2026, 101880, https://doi.org/10.1016/j.gendis.2025.101880

Funding
Deanship of Research and Graduate Studies at King Khalid University through the Large Research Project RGP2/95/46